SI1325022T1 - Metoda za pripravo 21-hidroksi-6,19-oksidoprogesterona (21oh-6op) - Google Patents

Metoda za pripravo 21-hidroksi-6,19-oksidoprogesterona (21oh-6op)

Info

Publication number
SI1325022T1
SI1325022T1 SI200130675T SI200130675T SI1325022T1 SI 1325022 T1 SI1325022 T1 SI 1325022T1 SI 200130675 T SI200130675 T SI 200130675T SI 200130675 T SI200130675 T SI 200130675T SI 1325022 T1 SI1325022 T1 SI 1325022T1
Authority
SI
Slovenia
Prior art keywords
oxidoprogesterone
hydroxy
preparation
phosphorlated
acylated
Prior art date
Application number
SI200130675T
Other languages
English (en)
Inventor
Gerardo Burton
Carlos P Lantos
Adriana Silvia Veleiro
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of SI1325022T1 publication Critical patent/SI1325022T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SI200130675T 2000-09-18 2001-09-17 Metoda za pripravo 21-hidroksi-6,19-oksidoprogesterona (21oh-6op) SI1325022T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00119494 2000-09-18
PCT/EP2001/010734 WO2002022646A2 (en) 2000-09-18 2001-09-17 Method for the preparation of 21-hydroxy-6,19-oxidoprogesterone (21oh-6op)

Publications (1)

Publication Number Publication Date
SI1325022T1 true SI1325022T1 (sl) 2007-04-30

Family

ID=8169774

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200130675T SI1325022T1 (sl) 2000-09-18 2001-09-17 Metoda za pripravo 21-hidroksi-6,19-oksidoprogesterona (21oh-6op)

Country Status (13)

Country Link
US (4) US7071328B2 (sl)
EP (1) EP1325022B1 (sl)
JP (1) JP2004509131A (sl)
AT (1) ATE344273T1 (sl)
AU (2) AU1817902A (sl)
CA (1) CA2419960A1 (sl)
DE (1) DE60124289T2 (sl)
DK (1) DK1325022T3 (sl)
ES (1) ES2271090T3 (sl)
IL (2) IL154776A0 (sl)
PT (1) PT1325022E (sl)
SI (1) SI1325022T1 (sl)
WO (1) WO2002022646A2 (sl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60124289T2 (de) * 2000-09-18 2007-09-06 Applied Research Systems Ars Holding N.V. Verfahren zur herstellung von 21-hydroxy-6,19-oxidoprogesteron (21oh-6op)
DE60129725T2 (de) * 2000-09-18 2007-12-06 Applied Research Systems Ars Holding N.V. Schwefel analoge von 21-hydroxy-6,19-oxidoprogesteronen (21oh-6op) zur behandlung von glucocorticoidüberschuss
US20100227806A1 (en) * 2006-03-10 2010-09-09 Tulipano Giovanni Use Of A Ghrelin Agonist To Improve Catabolic Effects Of Glucocorticoid Treatment
EP1862468A1 (de) * 2006-06-02 2007-12-05 Bayer Schering Pharma Aktiengesellschaft Kristallines 11beta-(4-Acetylphenyl)-20,20,21,21,21-pentafluor-17-hydroxy-19-nor-17alpha-pregna-4,9-dien-3-on
DE102009034368A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylenphenyl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034366A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylenoxyalkylenaryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034367A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzyliden-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102009034362A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034526A1 (de) 2009-07-21 2011-02-10 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-ethinylphenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102009034525A1 (de) 2009-07-21 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102010007719A1 (de) 2010-02-10 2011-08-11 Bayer Schering Pharma Aktiengesellschaft, 13353 Progesteronrezeptorantagonisten
DE102010007722A1 (de) 2010-02-10 2011-08-11 Bayer Schering Pharma Aktiengesellschaft, 13353 Progesteronrezeptorantagonisten
US9738817B2 (en) 2012-10-09 2017-08-22 Avery Dennison Corporation Adhesives and related methods
US20210355154A1 (en) * 2018-09-28 2021-11-18 The Regents Of The University Of Michigan Halogenated Cholesterol Analogues and Methods of Making and Using Same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3036068A (en) * 1960-01-06 1962-05-22 Syntex Sa C-6, 19-steroidal lactones
LU77457A1 (sl) * 1977-05-31 1979-01-19
US4814333A (en) * 1987-07-28 1989-03-21 The Trustees Of Dartmouth College Method for treatment of hypercortisolemic, depressed patients
GB9606016D0 (en) * 1996-03-22 1996-05-22 Smithkline Beecham Plc Novel use
EP0903146A1 (en) 1997-09-23 1999-03-24 Applied Research Systems ARS Holdings N.V. 21-Hydroy-6,19-oxidoprogesterone (210h-60p) as antiglucocorticoid
IL135469A0 (en) * 1997-10-06 2001-05-20 Univ Leland Stanford Junior Methods for treating psychosis associated with glucocorticoid related dysfunction
DE60124289T2 (de) * 2000-09-18 2007-09-06 Applied Research Systems Ars Holding N.V. Verfahren zur herstellung von 21-hydroxy-6,19-oxidoprogesteron (21oh-6op)
DE60129725T2 (de) * 2000-09-18 2007-12-06 Applied Research Systems Ars Holding N.V. Schwefel analoge von 21-hydroxy-6,19-oxidoprogesteronen (21oh-6op) zur behandlung von glucocorticoidüberschuss

Also Published As

Publication number Publication date
US20070249826A1 (en) 2007-10-25
DK1325022T3 (da) 2007-02-19
CA2419960A1 (en) 2002-03-21
DE60124289D1 (de) 2006-12-14
IL154776A0 (en) 2003-10-31
JP2004509131A (ja) 2004-03-25
PT1325022E (pt) 2006-12-29
EP1325022B1 (en) 2006-11-02
US7071328B2 (en) 2006-07-04
EP1325022A2 (en) 2003-07-09
WO2002022646A3 (en) 2002-06-06
WO2002022646A2 (en) 2002-03-21
ES2271090T3 (es) 2007-04-16
DE60124289T2 (de) 2007-09-06
WO2002022646A9 (en) 2002-09-19
AU2002218179B2 (en) 2006-11-16
ATE344273T1 (de) 2006-11-15
US20050277769A1 (en) 2005-12-15
IL154776A (en) 2007-07-04
AU1817902A (en) 2002-03-26
US20040092733A1 (en) 2004-05-13
US20090216008A1 (en) 2009-08-27

Similar Documents

Publication Publication Date Title
MXPA02012931A (es) Proceso para preparar un elastomero.
AU2002224893A1 (en) Method for producing a part and device for carrying out this method
SG147286A1 (en) Manufacture of polyglumate-therapeutic agent conjugates
GB9817052D0 (en) Vaccine
MXPA03009935A (es) Metodos e intermedios para preparar inhibidores 4-aminoquinolina de cetp.
EG23299A (en) Process for preparing 1-octene.
AU2001258447A1 (en) Method for transmitting messages
AU1817902A (en) Method for the preparation of 21-hydroxy-6,19-oxidoprogesterone (21oh-6op)
ZA200102070B (en) Process for preparing resorcinol derivatives.
MXPA03002010A (es) Metodo para producir un epoxido.
ZA200108623B (en) Process for preparing imidachloprid.
MXPA03001800A (es) Proceso para la preparacion de fenilacetonitrilos sustituidos.
ZA200209168B (en) Process for the hydroxylation of aliphatic compounds.
MXPA03001567A (es) Metodo para modificar eteres de celulosa.
IL156331A0 (en) A process for the preparation of paclitaxel
MXPA03002926A (es) Proceso para la sintesis de 2,2,6,6,-tetrametil-4--oxipiperidina.
ZA200104999B (en) Method for the production of formaldehyde.
MXPA03005569A (es) PROCEDIMIENTO MEJORADO PARA LA PREPARACION DE UN FARMACO ANTIMIGRAnOSO.
HK1044780A1 (en) Method for producing cyclo-)asp-dphe-nmeval-arg-gly).
AP2004002991A0 (en) Delimbing apparatus.
AU2001250429A1 (en) Method for producing 2-alkyl-3-chlorophenols
HK1040248A1 (en) Process for the preparation of isoindoline.
AU2001256674A1 (en) N-(heterocycle-methyl)alkylamine derivative, process for producing the same, andbactericide
MY123576A (en) Process for the selective n-formylation of n-hydroxylamines
AU2002241271A1 (en) Method for preparing 7-quinolinyl-3,5-dihydroxyhept-6-enoate